Podcasts about science: engineering

Tara sits down with one of her mentors, Dr. Daved Rosensweet, to have an important conversation about hormone replacement therapy (HRT) and why so many women are left in the dark when it comes to their options. Dr. Rosensweet has been at the forefront of bioidentical hormone therapy for years, and in this episode, he shares his deep expertise on how to approach HRT safely and effectively. They break down the fears and misconceptions that have prevented countless women from getting the support they need and discuss why personalized hormone therapy should be the standard—not the exception. Whether you're currently using HRT, considering it, or just want a better understanding of your options, this episode is a must-listen.   Key Talking Points Why hormones matter—they're not just about reproductive health, but essential for brain function, bone strength, and overall vitality. The shocking truth about declining hormone levels—they start dropping in your 20s and never stop. How misinformation about hormone therapy has kept women suffering needlessly. The Women's Health Initiative study—how it wrongly created fear around hormones and what the real science says. Bioidentical vs. synthetic hormones—why the form of hormones you use makes a massive difference. When to start hormone therapy—(hint: the earlier, the better). The importance of individualized dosing—why one-size-fits-all approaches don't work. How to find a knowledgeable provider who truly understands hormone therapy.   Dr. Rosensweet:  Daved Rosensweet, MD is the Founder of The Institute of BioIdentical Medicine and The Menopause Method, as well as the author of three books on the subject including his latest "Happy Healthy Hormones".  Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico. With over 30 years of experience specializing in Andropause and Menopause treatment, he is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on "The Safety and Efficacy of Bioidentical Hormones." Through The Menopause Method and The Institute of BioIdentical Medicine, Dr. Rosensweet is training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women. CUSTOMIZE TREATMENT PROGRAMS: The Menopause Method DOWNLOAD DR ROSENSWEET'S BOOK FOR FREE:  Happy Healthy Hormones     Mentioned in this episode: HRT Made Simple™ - Learn how to confidently speak to your doctor about the benefits of hormone replacement therapy so you can set yourself up for symptom-free, unmedicated years to come without feeling confused, dismissed, or leaving the medical office minus your HRT script. Hair Loss Solutions Made Simple™ – This course will teach you the best natural, highly effective, and safe solutions for your hair loss so you can stop it, reverse it, and regrow healthy hair without turning to medications. The Hormone Balance Solution™ – My signature 6-month comprehensive hormonal health program for women in midlife who want to get solid answers to their hormonal health issues once and for all so they can kick the weight gain, moodiness, gut problems, skin issues, period problems, fatigue, overwhelm, insomnia, hair/eyebrow loss, and other symptoms in order to get back to the woman they once were. [FREE] The Ultimate Midlife Perimenopause Handbook - Grab my free guide and RECLAIM your confidence, your mood, your waistline and energy without turning to medications or restrictive diets (or spending a fortune on testing you don't need!). BOOK A 30-MINUTE SESSION WITH TARA HERE   You might also like these episodes:   EPISODE 55: All about HRT including rhythmic dosing, Estradiol vs. Bi-Est & more with Dr. Felice Gersh PART 1 EPISODE 79: Do you need HRT if you don't have symptoms? What if you don't have hot flashes & you're still cycling regularly?  

Explore how innovative leadership principles and storytelling can transform personal and professional growth with 3M's Chief Science Advocate, Jayshree Seth. In this episode of The Innovation Show, Jayshree shares memorable acrostics and blueprints for success from her trio of books, discusses key elements of effective leadership, and delves into the importance of advocacy and diverse perspectives. Gain insights on balancing long-term vision with detailed execution and the role of positive emotions in fostering a creative and innovative environment.   00:00 Introduction and Guest Welcome 02:34 The Importance of Leadership 04:31 Leak Proof Leadership Explained 09:01 The Role of Storytelling in Innovation 11:08 The Five I's of Innovation 17:01 Advocacy and Leadership 22:24 Supervisory Skills and Employee Relationships 27:13 The Future is Already Here 28:35 Understanding Trends and Megatrends 30:35 The TNT Factor: Trends, Needs, Threats 31:24 Exploring the TREND Mnemonic 35:14 Bridging the Business-Technical Gap 41:39 Effective Leadership Communication 50:54 The Kaleidoscope of Leadership 56:58 Conclusion and Final Thoughts Jayshree previously on the show: innovation, Jayshree Seth, 3M, Chief Science Advocate, engineering, empathy, collaboration, patents, creativity, storytelling, visionary leadership, purpose-driven leadership, resilience, engineering innovation, STEM, scientific advocacy, women in science, leadership strategies

Julián Melo es un emprendedor apasionado por la educación y el desarrollo personal. Es ingeniero industrial egresado de la Universidad de los Andes y cuenta con un Master en Science Engineering por la misma institución. Además, cuenta con estudios en Stanford, Harvard y el MIT.Después de fundar dos emprendimientos anteriores, en 2014 fundó UBITS, el software "todo en uno" para recursos humanos, donde ayudan a las personas y empresas a crecer. A la fecha, UBITS cuenta con el catálogo más grande de contenidos online para capacitar empresas en español, ofreciendo más de 14,000 contenidos y trabajando con clientes en más de 15 países. Son parte de YC en Summer 18 y han levantado capital de grandes fondos como Riverwood Capital, Owl Ventures y Endeavor Catalyst. Julián es esposo, ángel inversionista y un emprendedor que nos enseña que el éxito es construir un impacto duradero ayudando a otros a crecer.

Cork-based software company CompuCal Calibration Solutions has partnered with Munster Technological University (MTU) to deliver a forward-thinking program that will benefit Science, engineering and manufacturing students across the Southwest region. This collaboration aims to prepare students by enhancing their digital skills to enable the digitisation of paper-based current and future processes within instrumentation, processing and manufacturing sectors by offering a real-world digital technology experience and solution, helping them tackle the evolving challenges. As part of this partnership, CompuCal's innovative calibration management software has been integrated into MTU's Department of Physical Sciences full-time, and industry-focused part-time Instrumentation and Calibration programme offerings, supporting modules on process control and instrumentation, calibration and asset management. These programmes will certify students in digital calibration, instrument maintenance, commissioning, and validation, positioning them to thrive in the data-driven, process-controlled industrial environments of tomorrow. MTU delivers approximately 1,500 STEM students annually, comprising approximately 10% of the national STEM cohort in Science & Engineering disciplines. This collaboration will provide these students with practical, hands-on experience using CompuCal's latest technology, simulating real-life operational challenges that engineers and technicians encounter in the manufacturing industry. This type of collaboration enables indigenous industry, which includes both SMEs and MNCs, to become globally competitive by partnership with companies such as CompuCal who have developed innovative solutions to meet the challenges of digitisation in modern industry. Donal Sullivan, CEO of CompuCal Calibration Solutions, welcomed the partnership, "In the highly regulated world of Biopharma, MedTech, and FMCG, calibration maintenance of assets is critical to keeping operations running smoothly. We are delighted to contribute to equipping Ireland's future engineers and technicians with the skills needed to meet the challenges of advanced manufacturing. MTU's leadership in adapting its curriculum to meet industry needs is crucial in shaping a workforce ready to face the rapidly evolving global manufacturing environment." Through this collaboration, MTU students will gain vital insights into asset measurement - ranging from temperature monitoring to pressure vessels - and will understand the essential role that calibration plays in ensuring production output, compliance with international standards, audit readiness, cost efficiencies, and business intelligence reporting. MTU's Donagh O'Mahony, Head of the Department, Physical Sciences, also highlighted the significance of the announcement, "This partnership reaffirms MTU's commitment to engaging with industry and enterprise. We are leveraging the exceptional expertise and innovation of an industry partner to support the development of future generations of talented MTU students. CompuCal has worked with us to review and update some of our core instrumentation and calibration modules, ensuring that they align with the latest in industrial best practice. The resulting changes best demonstrate the role of calibration in a live global manufacturing environment. This is directly relevant to our students, and we are excited by the value that is being added to our coursework and learning experience." The collaboration, which includes the recent incorporation of CompuCal GO, a mobile app designed for on-site technicians, ensures that MTU students are exposed to the latest technology in the field. This state-of-the-art tool provides a fully digital, paperless solution for calibration and maintenance tasks, integrating real-time data uploads directly to the CompuCal cloud platform. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podc...

How are organizations rethinking workforce strategies to stay flexible and innovative in today's rapidly changing landscape? This episode features a conversation with Hugo Malan, President of Kelly Science, Engineering, Technology & Telecom, where he shares insights on the shifts shaping workforce management and driving industries forward.  With a background in electronic engineering and extensive executive experience, Hugo has been instrumental in Kelly's strategic acquisitions of Softworld and Motion Recruitment Partners. These significant moves have strengthened Kelly's capabilities in areas like secure government talent and specialized tech staffing, introducing new thinking to their approach. Hugo discusses mixed labor strategies, blending full-time staff with temporary and project-based roles to create adaptable teams ready for evolving demands. He explains the benefits, including access to niche skills for short-term projects and the ability to adjust workforces effectively across economic cycles. Hugo also examines a recent shift in the temporary labor market, offering perspective on why the industry has seen reduced demand for temporary roles despite economic growth and what this trend may reveal about current business sentiment. For mid-career tech professionals, Hugo offers guidance on staying competitive, from upskilling to leveraging AI-driven tools that streamline workflows.

Researchers from Japan explore how the domesticated flightless silkworm moth (Bombyx mori), a prominent insect model in olfactory research, uses wing flapping to manipulate airflow, enhancing their ability to detect distant pheromones. These findings highlight how moths guide pheromones to their odour sensors in antennae and suggest potential applications for designing advanced robotic systems for odour source localization. This could inspire future innovations in drones and provide design guidelines for robots to locate odour sources. The silkworm moth (Bombyx mori) is an insect that no longer flies due to domestication. The males use their antennae to detect pheromones emitted by females, and they respond very acutely. They have been used as model insects for the study of their odor source localization. Flying insects flap their wings when they fly, and silkworm moths are also known to flap their wings (called fanning) when they detect pheromones, even though they do not fly. As pheromone molecules move through space in the air, the air flows produced by the flapping of wings undoubtedly have a strong influence on odour detection. However, the effect of this flapping of wings was not known quantitatively. To address this question, a group of scientists led by Dr. Toshiyuki Nakata from the Graduate School of Engineering, Chiba University, investigated how B. mori detects pheromones. "We understand that silkworm moths detect pheromones by flapping their wings to induce airflows around them. However, the precise impact of this wing flapping on the moths' ability to localize the odour source is unclear," explains Nakata while elaborating on the rationale for conducting this study. The team included co-first author Daigo Terutsuki from the Faculty of Textile Science and Technology, Shinshu University; Chihiro Fukui from the Graduate School of Science & Engineering, Chiba University; Ryohei Kanzaki from the Research Center for Advanced Science and Technology, The University of Tokyo; and Hao Liu, from the Graduate School of Engineering, Chiba University. Their study, published on August 2, 2024, in Volume 14 of Scientific Reports, employed high-speed photogrammetry - a technique that uses high-speed cameras to capture and reconstruct the motion and geometry of objects - to computationally analyze the aerodynamic consequences of wing motions of B. mori. Researchers meticulously recorded the wing movements during fanning and built a detailed computational model of the insects and surrounding airflow. Using the simulated data, they subsequently calculated the motion of particles that resemble the pheromone molecules around the fanning silkworm moth. One of the key findings of the study was that B. mori samples the pheromone selectively from the front. The moth scans the space by rotating its body while fanning to locate the pheromone sources. The directional sampling of the pheromone molecules is particularly helpful when searching for an odour source since the moth can determine the direction of the odour plume upon the detection of the pheromone. Needless to say, the implications of this research extend beyond the study of insects. The insights gained from how B. mori manipulates airflow could lead to advancements in robotic odour source localization technologies. A team led by Dr Daigo Terutsuki is working on developing drones equipped with insect antennae for odour detection, with potential applications such as locating individuals in emergencies. "The findings from this study highlight the importance of creating directional airflow when searching for odour sources using flying robots. This involves carefully adjusting the drone's orientation and the configuration of its propellers and odour sensors to optimize detection capabilities," notes Dr Nakata. Furthermore, the study highlights the need for future research to consider environmental factors such as airflow turbulence and antenna structure, which also influence odour det...

Join us as we dive into the California Science & Engineering Fair with teacher Colleen Duncan and standout student Michael Stodelle. Learn about the fair's impact and how to get involved, and hear how Michael's project last year reached the international stage! Google Classroom class codes: Elementary - cpdbbvo Secondary - mphc3gf

In this episode, joining us is Jayshree Seth, a leading STEM advocate and Chief Science Advocate at 3M, as she shares her insights on the science of innovation and thought leadership.

Episode 198 A pretty widely held view in the world of B2B products is that sales has gotten harder, not easier. It's not that buyers aren't buying. By definition, buying is something they do. But in the example of software, some sales reps won't even know they were being evaluated, let alone passed up for a rival's product. Only the winning vendor knows that that account uses them for that specific function in their technology stack. All other companies are in the dark.     But are they really? Another way to look at this is that every vendor has information that could be valuable to others. You can find many buyers stacks with products having some overlap but that largely complement each other. As proof, note that lots of these products even integrate with each other because of buyer demand.    Should vendors consider collaborating with vendors they compete against? Aren't we supposed to hate the competition?   We don't have to. A famous example of that was Apple's announcement in 1997 of the deal it struck with Microsoft. Steve Jobs defended the deal saying  “If we want to move forward…we have to let go of this notion that for Apple to win, Microsoft has to lose.”   Zooming to today's reality, It makes a lot of sense for vendors to collaborate as part of an Ecosystem. By pooling their data together with their indirect competitors, they can see internal buying patterns. Those vendors who hitch their data wagons together get around the ‘nobody talks to our sales rep' problem, because one of their partners already has the info that rep needs. Using this intel helps them come first in the race for their product to be selected to go in the buyer's stack.    Our guest today got a Science & Engineering degree from Princeton University and after a stint in the investment world, he dove into co-founding startups. The first was business intelligence platform RJMetrics and the other was cloud data pipeline company Stitch, both of which he saw through to successful exits.    His latest role is as Co-Founder of a platform that safely shares data among companies for this kind of partner-based selling.   Outside of work, He is a Trustee for one of America's top centers of science education and development And an improv comedy performer, in a  team that has performed over 100 shows together.   This husband, father of two, is very proud to call Philadelphia home. Let's head there now to meet Bob Moore.   Timestamps / Chapters 0:00:00 Intro 00:03:46 Bob's thesis on how sales is broken 00:11:21 Ecosystems are cause for hope 00:26:13 PSA 00:26:53 Revamping corporate partner practices 00:31:38 Pooling together data 00:55:06 Contacting Bob   Links to everything mentioned in the show are on the Funnel Reboot site's page for Episode 198  

A University of Galway delegation has taken part in a national fact-finding mission as part of Ireland's proposal for membership of CERN - the European Organization for Nuclear Research, where physicists and engineers are probing the fundamental structure of the universe. Professor James Livesey, University of Galway's Vice-President for Research and Innovation, and Dr Aaron Golden, Vice-Dean for Research and Innovation, at the University's College of Science & Engineering, visited the world's largest particle physics laboratory as part of an Irish delegation. An intergovernmental organisation based in Geneva near the border between Switzerland and France, CERN has 23 member states. Almost 3000 people are employed on the huge campus which every year plays hosts about 12,000 people from scientific institutions from more than 70 countries. CERN currently operates the most powerful particle accelerator in the world, the Large Hadron Collider (LHC), where proton beams moving at a fraction of the speed of light are smashed together, recreating, for an instant, explosions of energy that have only ever occurred at the origin of the universe, unlocking the fundamental constituents of matter. Vast experiments sweep up the blizzard of fragments, and painstakingly identify new physics - in the form of new types of matter. Work at CERN has resulted in no less than 5 Nobel prizes to date, most recently for the discovery of the Higgs Boson in 2012. Professor James Livesey, Vice-President for Research and Innovation, said: "This visit really emphasised to us all on the delegation the incredible value to University of Galway that Irish membership of CERN would bring, across so many levels. It is difficult to identify any other scientific facility in Europe that is such a source of wonder and inspiration and CERN's outreach mission is second to none. The creativity in physics and mathematics essential to understanding the most fundamental science possible using the LHC is mirrored in the creativity needed by the engineering and technical teams to build and operate these astonishing 'discovery machines'. Having Galway in the community of practice around CERN would make us members of one of the most creative and innovative groups in the world." The Irish delegation took part in a day-long visit to CERN, including tours of several of the currently operating particle and nuclear physics experiments on the campus, along with presentations and Q&A sessions with CERN personnel, highlighting the breadth of activities to which membership would give access to. Beyond its core mission of pushing the frontier of fundamental physics, CERN is heavily involved in the application of technology transfer to areas as diverse as algorithm development, network and computational infrastructure, materials science and medical physics. CERN operates a unique access programme for members, that provides funding for undergraduates, postgraduates and researchers to visit and work on site in areas that cover the full spectrum of its activities, with the graduate engineering training programmes being widely considered one of the best in Europe. Dr Aaron Golden, Vice-Dean for Research and Innovation, College of Science & Engineering said: "It was eye-opening to find out directly CERN's medtech innovation activities, from novel radiotherapeutics to medical device development to tumour biology modelling, and their support of member state colleagues in these areas. The University of Galway is uniquely placed to engage with such access, particularly with the recent opening of UHG's Saolta Radiation Oncology Centre." CERN will be sending a delegation to visit Ireland in April of this year to assess Ireland's application for membership. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor....

Subscribe to Receive Venkat's Weekly Newsletter Daniel took all the AP Classes his High School offered. He loved AP US History. He was also very active in the Science Olympiad and really enjoyed it because it involved building things. He was also fortunate to have been in a high school where there was a class dedicated to doing research. It was here that Daniel cut his teeth in research, and got his hands dirty doing Battery technology. Daniel joins our podcast to share his undergraduate college journey at UIUC, Battery Research, Winning the Goldwater Scholarship, Summer Internships, and Advice for High Schoolers. In particular, we discuss the following with him:  UIUC Experience UG Research - Battery Research The Goldwater Scholarship Advice to High Schoolers Topics discussed in this episode: Introduction to Daniel Cudzich, UIUC [] Hi Fives - Podcast Highlights [] Overall UIUCExperience [] Why UIUC? [] High School Interests [] Battery Research[] Why Battery Research [] Transition to UIUC [] Peers [] UG Research [] Impact of Research [] Why Goldwater Scholarship? [] The Goldwater Difference [] Summer Internships [] Advice for High Schoolers [] Memories [] Our Guests: Daniel Cudzich is a Goldwater Scholar studying Material Science & Engineering at University of Illinois Urbana-Champaign. Memorable Quote: “And this goes to one of the things that I really want to emphasize about the research process and it's that you will fail. You quite literally are doing things that nobody else has ever done. But there's so much value in that even if what you learned from the research project is what not to do, right. ” Daniel Cudzich. Episode Transcript: Please visit Episode's Transcript. Similar Episodes: College Experiences , UG Research Calls-to-action: Follow us on Instagram. To Ask the Guest a question, or to comment on this episode, email podcast@almamatters.io. Subscribe or Follow our podcasts at any of these locations: Apple Podcasts, Google Podcasts, Spotify.

In this podcast episode, host Ole Olesen-Bagneux welcomes Jesse Anderson, an esteemed figure in big data, Managing Director at Big Data Institute, and author of "Data Teams: A Unified Management Model for Successful Data-Focused Teams". Jesse shares insights from his experiences at Cloudera and as a software engineer, emphasizing a holistic approach to big data that integrates both technical skills and organizational strategy.Jesse highlights the importance of structuring data teams effectively, advocating for a triad of specialized groups: data science, data engineering, and operations. He critically assesses the common pitfalls companies face in big data, such as overestimating their capabilities and neglecting the organizational aspects essential for success.The conversation pivots to the evolution of big data, where Jesse addresses its maturity, challenges, and the misconceptions fueled by industry hype. He offers a pragmatic view on the value creation of data teams, urging a focus on tangible business outcomes and a strategic approach to technology adoption.

As we wrap up the last part of our season finale at the Global Greek Influence, we have embarked on an enlightening journey through materials science, chemical and mechanical engineering, healthcare, cybersecurity, blockchain, innovation, entrepreneurship, leadership, climate change, sustainable economy, education, and AI. The discussions with distinguished guests have illuminated the profound impact of Greek professionals in these fields, showcasing the intricate tapestry of their contributions to global scientific and engineering research. Although this marks the end of our current season, it signifies a celebration of a four-year journey, a testament to our dedication to exploring cutting-edge science, engineering, and technology research since December 2019. But our journey is far from over! Join us in June 2024, when more compelling conversations and insightful perspectives from an array of distinguished guests await you. Thank you all for being a part of this incredible journey. Stay tuned for our return in June 2024. Until then, keep exploring, stay curious, and embrace the ever-evolving world of science, engineering, and technology. Episodes Topics and Guests Curated and Investigated by Panagiota Pimenidou. --- Send in a voice message: https://podcasters.spotify.com/pod/show/panagiota-pimenidou/message

Join me for a special season-end two parts episode as we journey through four impactful years of the Global Greek Influence podcast. From unravelling the threads of science, engineering, and technology to exploring the influence of Global Greeks, we revisit, through my outlook, key moments and discuss the interplay of entrepreneurship, innovation, and sustainability. Explore topics ranging from history's impact on perceptions to questioning Roman propaganda's effects on Greek culture. We have delved into automobility, decision-making in crisis times, chemical engineering's role in space exploration, and more. Thank you for embracing diverse perspectives. As we bid farewell to 2023, stay tuned for a fresh format in June 2024. Grateful for an amazing four years—see you in the season finale on December 31, 2023! Want to become a guest? Or sign up for our latest news? Or simply follow new season updates and find all interesting forms? --- Send in a voice message: https://podcasters.spotify.com/pod/show/panagiota-pimenidou/message

Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico.He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.”Dr. R is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women.Highlights in this episode:Risks and benefits of hormone replenishmentHow much of each hormone is "your right amount"How to know it's time to start and what to look for in a hormone specialistHow to determine which hormones to replenishResources:https://iobim.org/https://brite.live/

Tune into the latest episode of the Myers Detox Podcast as we delve deep into the realm of anti-aging and hormone optimization with expert Dr. Daved Rosensweet. Discover why hormones play a pivotal role in the anti-aging process, from hormone testing and understanding your numbers to hormone replacement when needed. Learn about the pressing issue of declining sperm counts in men and how it impacts not only hormones and libido but also our ability to reproduce and our global population.  Dr. Rosensweet encourages both men and women, regardless of age, to take charge of their hormone health and offers practical advice on what your hormone levels should be, testing methods, and various replacement options, from pills and pellets to injections and creams. Find out how hormones are the secret to anti-aging, and uncover the truth about how toxins interfere with your hormonal balance. If you're ready to unlock the secrets of staying youthful, don't miss this enlightening episode featuring one of the top experts in the field. Your path to a healthier, more vibrant future starts with your hormones! On today's podcast, you will learn: How the myths of synthetic hormone replacement have been dispelled. Studies show that women who are treated with hormones are at less risk for breast cancer, heart attack and stroke than women who go untreated. What the benefits of hormone replacement are, including slowing cognition decline; protecting bone, skin, and artery health; preventing muscle loss; restoring libido; and as anti-aging agents. About hormone testing, including the difference between a 24 hour urine hormone test and the DUTCH test. The most effective and safest way to take hormone replacements. You absorb hormones better when they're applied to your skin and it allows you more control of dosing. This works especially well with estrogen and progesterone. Why Dr.. Rosensweet often supplements hormones with DHEA, especially with testosterone. The body uses DHEA to make androgens and estrogens, the male and female sex hormones. DHEA levels peak at about age 25, then go down steadily as you get older. That the way to a healthy life takes so much more that hormone replacement. It requires physical effort, including exercise and nutrition, as well as emotional work: learning your triggers and how to handle the stress in your life to prevent the added stress on your body. How you can get a free download of Happy Healthy Hormones.   Dr. Daved Rosensweet's Bio: Dr. Daved Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, he trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico. Dr. Rosensweet is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), and The Age Management Medicine Group (AMMG), as well and others. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.” Dr. Rosensweet is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master Compounded Bioidentical Hormone Replacement Therapy (cBHRT) using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women. You can learn more about Dr. Rosensweet and his work at davedrosensweetmd.com ✨SUBSCRIBE✨ http://bit.ly/38pyo1U

About Dr. Daved Rosensweet: Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico. He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.” Dr. Rosensweet is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women.   What We Discuss In This Episode: Dr.  Daved discussed the misconceptions surrounding hormone therapy for women in menopause, emphasizing that studies have shown a lower risk of breast cancer, heart attack, and stroke for women treated with hormones. He also highlighted the limitations of relying solely on blood tests to determine menopausal status and the importance of considering symptoms and medical history. Dr. Daved and Lynne discussed the importance of testing hormone levels in women with irregular cycles and the individualized approach to hormone treatment using compounded bioidentical hormones. They also mentioned the potential benefits of hormone treatment for women in perimenopause and post-menopause, considering factors such as cardiovascular health. Dr. Daved discussed his approach to hormone therapy, emphasizing the importance of individualized treatment based on hormone levels and symptoms.  Dr. Daved discussed the best forms of treating women with hormones; Pills? Injections? Topical to skin and mucous membranes? Pellets? If a woman isn't in menopause or her symptoms are mild, what should she do?   Free Resource from Dr. Rosensweet: FREE pdf copy of Dr. Rosensweet's latest book -  Happy Healthy Hormones: https://iobim.org/book/   Connect with Dr. Rosensweet: Website: https://iobim.org/ Website: Brite.live Facebook: https://www.facebook.com/groups/1124278224398950 Instagram:  https://www.instagram.com/menopausedoctor/   Connect with Lynne: If you're looking for a community of like-minded women on a journey - just like you are - to improved health and wellness, overall balance, and increased confidence, check out Lynne's private community in The Energized Healthy Women's Club. It's a supportive and collaborative community where the women in this group share tips and solutions for a healthy and holistic lifestyle. (Discussions include things like weight management, eliminating belly bloat, balancing hormones, wrangling sugar gremlins,  overcoming fatigue, recipes, strategies, and much more so women can feel energized, healthy, confident, and joyful each day. Website:  https://holistic-healthandwellness.com Facebook: https://www.facebook.com/holistichealthandwellnessllc The Energized Healthy Women's Club:  https://www.facebook.com/groups/energized.healthy.women Instagram: https://www.instagram.com/lynnewadsworth LinkedIn:  https://www.linkedin.com/in/lynnewadsworth   Free Resources from Lynne Wadsworth: How to Thrive in Menopause:   MENOPAUSE Messing Up your life?  Maybe you're seeing the number on the scale creep higher and higher and you're noticing your usual efforts to lose weight aren't working. Then there's the hot blazes, night sweats, and sleeping fitfully, not to mention that you're fighting tears one moment, raging the next, and then, the shameful guilt sets in because you've just blasted your partner – for nothing…again! Learn how to successfully and holistically navigate perimenopause and full-blown menopause, and even reconcile all the hormonal changes and challenges that go along with it. You'll be feeling energized, healthier, and more in control so you can take on your day confidently and live life joyfully – even in menopause. I've got this FREE solution tool for you.  Download my guide here: https://holistic-healthandwellness.com/thrive-through-menopause/   5  Simple Steps to Gain Energy, Feel Great & Uplevel Your Health: Are you ready to create a Healthier Lifestyle?  Would you like to feel lighter, more energized, and even add joy to your life? If it's time to find more balance of mind~body~soul, then I've got the perfect FREE resource to help.  In this guide, you'll find my most impactful strategies and I've made applying them in your life as simple as 1-2-3 (plus a couple more) to help you create a healthier, holistic lifestyle. Uplevel your holistic health and wellness and download the 5 Simple Steps to Health  here:  https://holistic-healthandwellness.com/5-simple-steps-to-a-healthier-you/   Did You Enjoy The Podcast? If you enjoyed this episode please let us know! 5-star reviews for the Living Life Naturally podcast on Apple Podcasts, Spotify, Pandora, or Stitcher are greatly appreciated. This helps us reach more women struggling to live through midlife and beyond. Thank you. Together, we make a difference!  

Many women who experience menopausal symptoms can easily feel overwhelmed and frustrated. From hot flashes and night sweats to vaginal symptoms and mood changes, the menopause transition can take a significant toll on a woman's body and quality of life. In this episode, Cody has invited Dr. Daved Rosensweet to be a guest and help us learn more about hormone replacement therapy (HRT), a popular treatment for postmenopausal women. In this episode, we will learn about the pro's and con's of hormone replacement therapy, and see if this treatment is best for you!Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico.He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.”Dr. R is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women.Dr. Rosensweet's Ebook: Happy Healthy HormonesDavedRosensweetMD.comSuggested Mixhers Supplement: HerthriveDid you learn something new today? Be sure to subscribe to this podcast and share this episode with all the girls you love. We would appreciate it if you'd also leave us a rating and review on iTunes.You can watch full episodes on YouTube now as well. Like and Subscribe to the It's Hertime Podcast HERE!Want to join our Mixhers Girl community and keep this conversation going? We'd love to hear your thoughts, feelings and experiences! Join us HERE!Join Mixhers email list and be the first to have access to new products and be the girl in the know!Follow Cody and Jess on Instagram:@codyjeansanders@jesstoolson@mixhers

Quantum Nurse www.quantumnurse.life presents On  Wednesday, August 23, 2023 @ 12:30 PM EST 5:30 PM UK 6:30 PM Germany Guest: Dr. Daved Rosensweet, MD Topic: Happy, Healthy Hormones: How to Thrive in Menopause.   https://www.davedrosensweetmd.com/ Bio:  "Daved Rosensweet MD is the Founder of The Institute of BioIdentical Medicine and The Menopause Method, as well as the author of three books on the subject including his latest "Happy Healthy Hormones". Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico. He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.” Through The Menopause Method and The Institute of BioIdentical Medicine, Dr. Rosensweet is training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women.  . Here is a short clip of Dr. Rosensweet talking about how he began to do the work he does https://www.youtube.com/watch?v=7LQJ06TXGQ8   Additional resources: https://compounding.com/ Subscribe to Dr. Daved Rosensweet's  newsletter and Download Dr. Rosensweet's book “Happy Healthy Hormones” for free https://iobim.org/book/     TIP/DONATE LINK for Grace Asagra @ Quantum Nurse Podcast https://patron.podbean.com/QuantumNurse https://www.paypal.com/donate/?hosted_button_id=FHUXTQVAVJDPU Venmo  - @Grace-Asagra 609-203-5854                                     Interview Panel   Grace Asagra, RN MA (Holistic Nurse, US, originally from the Phil) Podcast:  Quantum Nurse: Out of the Rabbit Hole from Stress to Bless www.quantumnurse.life Quantum Nurse - Bichute https://www.bitchute.com/channel/nDjE6Ciyg0ED/ Quantum Nurse – Apple https://podcasts.apple.com/us/podcast/quantum-nurse-out-of-the-rabbit-hole-from-stress-to-bliss/id1522579988 Quantum Nurse Earth Heroes TVhttp://www.earthheroestv.com/categories/the-freedom-broadcasters?via=grace Quantum Nurse Rumble https://rumble.com/c/c-764837 Quantum Nurse Podbean https://graceasagra.podbean.com Quantum Nurse ClikView   https://clikview.com/?ref=410070342631952c00a47c0.19349477 Quantum Nurse ClikView https://clikview.com/@QuantumNurse

    Andrea Costa  is a qualified chartered engineer and building energy rating (BER) assessor in Italy and a Certified Energy Manager (CEM) affiliated to the Association of Energy Engineers (AEE).    He is expert in building simulation with experience on an array of building energy simulation software and ISO 50001 certification tools. Andrea is originally a graduate from the Politecnico di Milano where he obtained a BSc(Eng) in Building Engineering in 2005.    In 2007 he was also awarded a summa cum laude Masters of Science degree in Building Engineering. During the master degree programme, he was awarded an Erasmus Scholarship and studied at University College Cork in the academic year 2005/2006.    He pursued and was awarded a PhD in Civil Engineering from the National University of Ireland Galway (NUIG) with a PhD topic of providing support to the energy manager in improving the building operation strategy with considerations on building energy use and occupant comfort throughout the building lifecycle.    After his PhD, Andrea was awarded an industrially supported Postdoctoral Fellow co-funded by IRCSET (Irish Research Council for Science Engineering and Technology) as part of the Enterprise Ireland Partnership Scheme and D'Appolonia Spa in Italy.    Andrea brings with him a balance of field and research experience including FP7 projects for energy efficiency with targeted focus for office buildings, airports, sport facilities, and schools.   Show Highlights Play sustainability Legos to inspire your direction. Aims and innovative solutions and technologies to speed up change to the construction industry and the real estate industry. Research funded projects to support green building consulting and projects. R2M focus and industry impact    Making buildings more digitally sustainable and eco digital. Understanding new European directive for building energy efficiency Educating stakeholders to manage their own assets.  A framework for digital initial log books directly working with requirements and guidelines for green building. Unique approach to digitizing and keeping digital data available for buildings during daylight time. Providing internal occupants with the digital solutions that maintain better conditions. Understanding the difference between the European Green Deal and EU taxonomy mandates and priorities.  The secret to growing a sizable business for budding entrepreneurs.   Transform buildings into digital assets.  “Find the right balance or the mood of the dial. When you are very excited, it's easy. Longer when you are very frustrated, it's easier to reduce. The challenge is when you're frustrated, you should try to keep pushing a bit more than when you would like to stop. And when you are super excited, you should try not to overwork too much because otherwise another dry spell of being not so excited will come. It's a hard balance to keep.” -Andrea Costa     Show Resource and Information Connect with Charlie Cichetti and GBES   GBES is excited our membership community is growing. Consider joining our membership community as members are given access to some of the guests on the podcasts that you can ask project questions. If you are preparing for an exam, there will be more assurance that you will pass your next exam, you will be given cliff notes if you are a member, and so much more. Go to to learn more about the 4 different levels of access to this one-of-a-kind career-advancing green building community!   If you truly enjoyed the show, don't forget to leave a positive rating and review on .  We have prepared more episodes for the upcoming weeks, so come by again next week! Thank you for tuning in to the !   Copyright © 2023 GBES

This year's conference brought Industry together with the Department of Defense Research, Engineering, Acquisition, and Sustainment communities to examine the investment priorities and challenges across the OSD, Components, Agencies and Combatant Commands, including top-level strategy updates from Component and COCOM S&T leadership. Special featured topics for this year will include the S&T needs of the HA/DR mission as well as success stories from the SBIR program. Join Dr. Arun Seraphin and James Chew, NDIA's S&ET Chair and Senior Global Group Director of Aerospace and Defense at Cadence Design Systems to learn more about what the conference's priorities were.

In this episode of Hope Natural Health, Dr. Erin speaks with Dr. Daved Rosensweet about fighting obesity. Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado.  Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico. He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more.  In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.” Dr. R is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women. During this episode you will learn about: How hormones impact every aspect of our well-being Reasons why hormone replacement therapy gets such a bad rap   Link to Testing: https://hopenaturalhealth.wellproz.com/   Link to Period Planner:  https://www.amazon.com/dp/B0BBYBRT5Q?ref_=pe_3052080_397514860 For more on Dr. Erin and Hope Natural Health: Take the Period Quiz: https://form.jotform.com/230368188751059 Check out my Hormone Reset Program: https://hopenaturalhealth.practicebetter.io/#/619ef36b398033103c7b6bf9/bookings?p=633b5cca8019b9e8d6c3518d&step=package Dr. Erin on Instagram: https://www.instagram.com/dr.erinellis/ Dr. Erin's Website: https://hopenaturalhealth.com/ Hope Natural Health on YouTube: https://www.youtube.com/channel/UChHYVmNEu5tKu91EATHhEiA Follow Hope Natural Health on FB: https://www.facebook.com/hopenaturalhealth

Have you heard of hormone replacement therapy? Most of us have and unfortunately many are worried about using it. Or we just don't realize the importance. Dr. Rosensweet labels the early 2000's study on HRT and then the resulting press coverage as “outrageously odd, crazy, misogynistic.” Basically it was completely incorrect and led to women being afraid to receive HRT.  In this episode, you will learn here how incredibly protective hormones are to women's health. Remember that menopause is actually a fairly new occurrence in human history. He says “You know, for the couple hundred thousand years humans have been alive, there was no such thing as menopause!”We are living longer, but we want to also live better, and you'll see here today that hormones are essential to making our health span match our life span. Download Dr. Rosensweet's book HEREMEDICAL DISCLAIMER: this podcast is for informational purposes only. Please discuss all treatment with your personal physician or medical care provider and come to your own conclusions. About Dr. Rosensweet:Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico.He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.”Dr. R is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women.More from Dr. Rosensweet:Website: www.menopausemethod.comInstagram: @menopausedoctorMore from Well with Lisa:Join the Group Coaching Program Waitlist HEREYour Go-To Meal Guide: grab it HERESchedule your free strategy session: wellwithlisa.as.meLet's be friends! Follow me on instagram:  @well_with_lisa

Dedicated to the memory of Co-Host Kenny Lowe Patricia Haley-Glass, is an award winning national bestselling author. (13 books)  She earned the title of “trailblazer” after achieving remarkable success with her debut faith-based novel in 1998. The self-published novel, Nobody's Perfect, sold nearly 20,000 copies in an industry where selling 5,000 copies at the time was highly regarded. The novel was first of its kind to repeatedly make numerous national best sellers list, including #1 on the Essence list. Her next book, No Regrets, tackled the marital, personal, and financial impact breast cancer has on a family. It was popular among readers and followed Nobody's Perfect onto the best seller's list. With both a B.S. in Industrial Engineering and a B.S. in Management, Science & Engineering degree from Stanford Univ. coupled with an M.B.A. that focused on finance and marketing from the Univ. of Chicago, readers are often surprised to hear that Patricia is writing novels, given her technical and business background. Patricia's literary mission is evident in her books: create entertaining, ‘clean' stories that tackle real issues and affirms the power of forgiveness while leaving readers with a message of hope, no matter what the circumstance Website: www.patriciahaley.comEmail: phg@patriciahaley.com or pop@anointedvision.com Facebook: Patricia Haley-Glass or at fan of Author Patricia Haley  

We have to agree with today's guest:  hormones are one of the most potent and powerful drugs with the ability to give life changing outcomes that impact not just the patient, but lives around them! Back by popular request-more talk about HORMONES and specifically bioidentical hormone replacement therapy for both women and men. Dr. Daved Rosensweet joins us today. He is an expert in the field and one of the pioneers in HRT. He has founded The Menopause Method and Brite.live, which offers healthcare professionals guided training and expertise and tools to provide the best treatment for patients. He has also written a book, Happy Healthy Hormones which educates patients as to the basics of hormone therapy so you can educate yourself to your individual needs. His passion for changing lives is very evident and he continues to be involved in educating others to make life changing impacts on patients lives. Some highlights from today's discussion:  -all the delivery methods (pellets, pills, creams, gels, oils, etc..), why it matters and how to choose   -how to find a reputable prescriber & what to look for in a hormone specialist -does testing matter to determine proper dosages and which test is best? -What are the best forms of treating women with hormones? Pills? Injections?  Pellets? -key points in treating men? More about our Guest: Daved Rosensweet M.D. Dr. Rosensweet graduated from the University of Michigan Medical School in 1968. Since 1971, he has been in private medical practice, with offices in Florida, New Mexico, California, and Colorado. Early in his career, Dr. Rosensweet trained the first nurse practitioners in the United States and was in charge of health promotion for the State of New Mexico. He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on “The Safety and Efficacy of Bioidentical Hormones.” Dr. R is the Founder of The Menopause Method and The Institute of BioIdentical Medicine, where he has been training medical professionals to master cBHRT using the most advanced and modern tools. His protocol has been used to treat more than 12,000 women. Links! https://brite.live/ https://iobim.org https://www.davedrosensweetmd.com https://www.menopausemethod.com https://iwonderdoctor.com/#welcome Our Advice! Everything in this podcast is for educational purposes only. It does not constitute the practice of medicine and we are not providing medical advice. No Physician-patient relationship is formed and anything discussed in this podcast does not represent the views of our employers.  The Fine Print! All opinions expressed by the hosts or  guests in this episode are solely their opinion and are not to be used as specific medical advice.  The hosts,  May and Tim Hindmarsh MD, BS Free MD LLC, or any affiliates thereof are not under any obligation to update or correct any information provided in this episode. The guest's statements and opinions are subject to change without notice. Thanks for joining us! You are the reason we are here.  If you have questions, reach out to us at doc@bsfreemd.com or find Tim and I on Facebook and IG. Please check out our every growing website as well at  bsfreemd.com (no www)  GET SOCIAL WITH US! Website: bsfreemd.com Rumble: https://rumble.com/search/video?q=bsfreemd Instagram:: https://www.instagram.com/bsfreemd/ Facebook: https://www.facebook.com/bsfree Coming Soon: YouTube Channel!

Have you ever experienced the feeling of not being yourself?As we age, our bodies also change. There are cycles that help with our hormones that eventually come to an end. Some examples being the menstrual decay, and as well as the degradation of testosterone levels as the years go by. But these processes ending doesn't mean you just have to accept that that is how life is going to be.In this episode, Kashif is joined by the founder of The Menopause Method, Dr. Daved Rosensweet. Over the years he has worked towards the expertise of menopause and hormone replacement therapy which sprouted from a personal story of speaking with an expert on progesterone. He is also the founder of I Wonder, Doctor, and as well as the Institute of BioIdentical Medicine. He is a nationally known lecturer and presenter at The American Academy of Anti-Aging Medicine (A4M), The American College for Advancement in Medicine (ACAM), The Age Management Medicine Group (AMMG), and more. In 2019, he was called to Washington to speak in front of The National Academies of Science Engineering and Medicine (NASEM) on "The Safety and Efficacy of Bioidentical Hormones."They discussed about how hormone replacement therapy took off until there were false stories in 2002 that changed the perspective of the people and put hormone therapy in a bad light. People thought that it would increase the risk of breast cancer and other diseases. But what is the truth about hormones?Hormones are actually a way to resolve diseases at the root cause especially since menopause affects women's anxiety, depression, physical, and psychological health. Hormones are capable of lessening risks of heart attack and breast cancer. As for men, hormones help with the symptoms of testosterone degradation. Kashif and Dr. Rosensweet also discuss the following points:The peak years of men and womenPre-menopause and menopausal stagesProper application/intake of hormonesThe circadian rhythm of hormone flowHormone testingThe insufficiency and overdose of hormonesIf you wish to learn more about Dr. Rosensweet and his work, you may click through the links below:You may avail of a free copy of his book, "Happy Health Hormones: How to Thrive in Menopause" through https://iobim.org/book/Websites:www.brite.livewww.iobim.orgwww.menopausemethod.comhttps://iwonderdoctor.com/#welcomehttps://www.davedrosensweetmd.com________________________________________________________________________________Don't forget to grab yourself a copy of Kashif Khan's book, "The DNA Way: Unlock the Secrets of Your Genes to Reverse Disease, Slow Aging, and Achieve Optimal Wellness" which is now available for presale!Follow Kashif Khan to receive updates on the UNPILLED Podcast!This episode may also be streamed on YouTube!

Jessica Holden & Debbie Johnson/Gwinnett County Public Schools The Gwinnett Regional Science, Engineering + Innovation Fair will be held on Friday, February 24, 2023 at the Gas South Convention Center. This event highlights student innovations in STEM and collaboration with community professionals as judges to ensure the best and brightest students represent Gwinnett at the […] The post 2023 Gwinnett Regional Science, Engineering + Innovation Fair appeared first on Business RadioX ®.

An interview with Dr. Lydia Villa-Komaroff

Torey founded BrandCraft in 2012. An artist at heart with an entrepreneurial spirit. Torey's background winds through Science & Engineering (a registered Civil Engineer) until he decided to chase his true passion – marketing. After short stints away, the Tri-Cities area lured him back to plant roots and put up shop. Free time consists of golf, coaching, beer tasting (12oz tasters), and photography.

"The value of researchers in science, engineering and technology" is about i) re-inventing their research field and bringing transparency to the new market and economy, ii) creating an environment where researchers can also thrive as individuals based on their talents and human approach, iii) enjoying more every moment and step without worrying too much or striving for perfection. I am talking to Dr Vassilis Katos, a Professor of Cybersecurity and Head of the Computer Emergency Response Team at Bournemouth University (BU-CERT) in the U.K., Dr Kostas Stylidis CEO and Co-Founder of Intended Future, an Associate Professor at University West and part-time associate researcher at the Chalmers University of Technology in Sweden, Professor Anna Stephanopoulou, William Clay Ford Professor of Technology, from the Department of Mechanical Engineering at Michigan University, Ann Arbor in the U.S. and Dr Constantine Stratakis, Chief Scientific Officer, ELPEN, Athens, Greece- Director (Res. A'), Human Genetics & Precision Medicine at Foundation for Research and Technology - Hellas (FORTH) in Greece. Music: "Fortitude" by Humans Win Source: Storyblocks --- Send in a voice message: https://anchor.fm/panagiota-pimenidou/message

What we're talking about: Today I'm speaking with two guests about their roles in the construction industry. The first is Jackson, the Managing Director of iBuild Building Solutions, and he shares about innovation within the industry and where he sees the future of construction in Australia. We also hear from Elizabeth who is about to complete a Master of Engineering from The University of Melbourne. Her current role at iBuild is as a technologist and she shares great information about her course and the type of work she does day-to-day. Innovation in Construction Technologies Jackson explains that at iBuild they provide kit homes and modular buildings to residential, commercial and government clients. He shares the ways in which they use new technologies such as video immersion capabilities, virtual reality and augmented reality to better design before they build, as well as how offsite construction technologies reduces the environmental impact and improves safety. This gives us an insight into the future of construction in Australia. Bachelor of Science/Master of Engineering at The University of Melbourne Elizabeth completed her secondary schooling in Darwin, and she explains how she went about researching and applying to interstate universities. She chose to study Engineering at The University of Melbourne through the Science/Engineering pathway, starting with a Bachelor of Science followed by a Master of Engineering. Elizabeth gives us an insight into the course and the opportunities she had to explore what a career in engineering would look like. Civil Engineering Elizabeth initially wanted to pursue Architecture because she thought that it would allow her to combine her interests of design and maths, however when she did work experience at an architecture firm and asked about the types of maths they use, she was told not to worry - the engineers do that part! She immediately changed her focus to engineering, and in this conversation she explains really clearly what engineering is and what she does in her role at iBuild as she works towards becoming a civil engineer. Links mentioned: My website: https://www.roadmapeducation.com Monash Tech School: https://www.monashtechschool.vic.edu.au/ Bachelor of Science/Master of Engineering at The University of Melbourne: https://eng.unimelb.edu.au/students/preeng-it/science-pathway iBuild Building Solutions: https://www.ibuild.com/

An interview with Dr. Lydia Villa-Komaroff, molecular biologist and diversity advocate.

"See challenges as an invitation to innovate." Adam Woods is moving into his 17th year of Science Engineering teaching at Segerstrom High School in Santa Ana, CA. Adam has spent the past 8 years developing and maintaining the first Aerospace Engineering Pathway in Orange County, which consists of 3 successive Engineering courses designed to better prepare underrepresented students for STEM majors at the college level. Adam's passion for STEM education includes a deep commitment to leveling the playing field for young women pursuing Engineering or Computer Science. Adam has been a club advisor for “Girls Who Code”, “Sisters In Engineering”, and the Cal Poly Pomona “Femineer” program – all with the goal of closing the gender gap in technical professions. Looking into the future, Adam hopes to one day implement Environmental Engineering at his school site and create a synergetic Aerospace, Environmental Computer Science Academy.David Rhodes co-presented with Dr. Mark Ellis at the National Council of Teachers of Mathematics (NCTM) annual Boston conference regarding detracking the 7th-grade mathematics classes at Lathrop. Their presentation is titled "We Must Stop Sorting Students": One Teacher's Experience with Detracking. David's personal qualities of being reflective and collaborative make him a good team player and student advocate. Understanding that one can never stop learning, he seeks opportunities to improve his ability to teach and demonstrates a strong responsibility for the teaching profession by mentoring teachers, parents, and students to not only advocate for themselves but always be learning.

Last month, UN members convened at the UN Environment Assembly and passed a historic resolution to end plastic pollution. On this week's episode we're looking at what plastic is, how it can biodegrade, what biodegradable even means and what we can do to start taking plastic out of our everyday life. Dr. Ting Xu is a professor in the Department of Science Engineering and the Department of Chemistry at the University of California at Berkeley. Sarah Paiji Yoo is the CEO and co-founder of Blueland, a company that has committed to revolutionizing conventional cleaning and personal care products.

“Enjoy the journey so you can relish the time on the core things you want.” - Adam Blakney"You're going to have to live in the world as it is today. Not in the world that maybe we wish we had” - Josh PeckRunning a lean single-family office isn't easy, and Adam Blakney runs the daily gambit of public portfolios, real estate, direct investments, and various board positions to keep the family on track towards its vision for future generations. Adam says that the money is the easy part and his principal focus is on the people, the health of the family, education, and ensuring that the plans the family makes now will create value, not just financial for future generations. Through history as well as personal experience, Adam has discovered that the best-laid plans of previous generations have been rendered obsolete in current times, demanding new ideas and new paths forward.Since every single-family office is unique, Adam has relied on his MBA from Melbourne Business School, as well as his experiences in startup to build his single-family office from the ground up building a team of suppliers and advisors to help navigate these unchartered waters.Joshua M. Peck is the founding member of the TrueCode Capital with nearly 20 years developing and capitalizing on emerging technologies. He utilizes a systems approach to portfolio management that leverages his deep quantitative background in financial engineering, machine learning, and applied mathematics.Early in his career, Josh worked in academia in support of high-performance research computing environments where he became a regional expert in systems engineering, cyber security, and data engineering. In addition to his work, he is active in philanthropy through the Denver Mile High Rotary Foundation, where he is currently the treasurer and a member of the World Community Service Committee where most recently they were able to fund a cold storage project in Nepal.Josh has served as an advisory board member, angel investor, and mentor for various venture clubs and accelerators, and has invested in a diverse group of companies.Josh received his BS in Computer Science from Pittsburgh state university and his Master's of Science Engineering, Management from the University of Kansas.Please enjoy! Click here to subscribe to The Sell My Business Podcast to save time and effort. SELECTED LINKS FOR THIS EPISODEAdam Blakney on LinkedInJosh Peck on LinkedInThe Deep Wealth ExperienceFREE Deep Wealth eBook on Why You Suck At Selling Your Business And What You Can Do About It (Today)Book Your FREE Deep Wealth Strategy Call Did you enjoy this episode of The Sell My Business Podcast? Please leave a review. Reviews help me reach new listeners, grow the show, and continue to create content that you'll enjoy.Please click here to leave a review on The Sell My Business Podcast. This podcast is brought to you by Deep Wealth. Your liquidity event is the most important financial transaction of your life. You have one chance to get it right, and you better make it count. But unfortunately, up to 90% of liquidity events fail. Think about all that time, money and effort wasted. Of the "successful" liquidity events, most business owners leave 50% to over 100% of their deal value in the buyer's pocket and don't even know it.Our founders said "no" to a 7-figure offer and "yes" to a 9-figure offer less than two years later. Don't become a sta

Shopify has over 1.7 million merchants across over 175 countries, with hundreds of millions of consumers shopping at their stores. By leveraging the scale of their data they are able to create new experiences for their merchants, and apply Machine Learning at scale. In this episode of the AI Today podcast, hosts Kathleen Walch and Ron Schmelzer interview Ella Hilal, who is the Head of Data Science, Engineering, Revenue and Growth at Shopify. Continue reading AI Today Podcast: Implementing AI at Scale, Interview with Ella Hilal, Head of Data Science, Engineering, Revenue and Growth at Shopify at Cognilytica.

How do you talk to patients about medicinal cannabis? Dr. Ashley Glode (University of Colorado) moderates a discussion on effectiveness and safety, misconceptions and more. Featuring Drs. Ilana Braun (Dana-Farber Cancer Institute), Daniel Bowles (University of Colorado), and Kent Hutchison (University of Colorado). Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air Date: 1/19/22   TRANSCRIPT ASHLEY GLODE: Hello, and welcome to ASCO Education's podcast on medical cannabis, also referred to as medical marijuana. My name is Ashley Glode, and I am an associate professor with the University of Colorado School of Pharmacy. It's my pleasure to introduce our three guest speakers Dr. Ilana Braun is chief of the division of adult psychosocial oncology at Dana-Farber Cancer Institute, and an assistant professor of psychiatry at Harvard Medical School. Dr. Daniel Bowles is an associate professor of Medical Oncology at the University of Colorado. We're also joined by Dr. Kent Hutchison, a professor of psychology and neuroscience at the University of Colorado Institute of Cognitive Science. Let's start with a simple but fundamental question. What is medical cannabis or medical marijuana? ILANA BRAUN: So Ashley, I think that's such a great first question. I think of medicinal cannabis as herbal nonpharmaceutical cannabis products that patients use for medicinal purposes. And typically they're recommended by a physician in compliance with state law. DANIEL BOWLES: Dr. Braun makes a really good point. And I think it's important to know when patients are referring to medical cannabis, there's a wide variety of different things they could be referring to. Sometimes they would be referring to smoked herbal products, but there are also edibles, tinctures, ointments, creams, all sorts of herbal-based products that people use and call medical cannabis. And then there are also the components that make up medical cannabis-- largely, the cannabinoids. And I think the big ones people think about are THC and CBD. And sometimes those are used in their own special way. So I think that it's important for us as providers to be able to ask our patients, what is it that you mean when you say, I'm using medical cannabis? ILANA BRAUN: I think that's such a great point. And I will add I think it's also important to remember that when you offer a medicinal cannabis card to a patient, you're giving them license in most states to access any number of products. It's not an insurmountable challenge, but it's a whole new world for traditional prescribers who are used to writing a prescription and defining what is the active ingredient, how often a patient will take the medicine, by what means. DANIEL BOWLES: I think the other thing we need to be very aware of, as hopefully people are listening to this across the country and elsewhere, is the laws vary wildly from jurisdiction to jurisdiction about what consists of medical cannabis, who is allowed to use it, and in what quantities. So I think it's really important that as we learn about these and we think about these, we think about how they apply to any of our specific situations in which we live in practice. KENT HUTCHISON: So it's interesting-- just follow up on what Dr. Braun and Dr. Bowles, what they're saying, those two words-- right-- medical and cannabis. I think the medical part is somewhat easier because it can refer to the reason the person is using. Are they using for medical reasons are they using for recreational reasons, even though that's a blur? But the cannabis part I think is what's really complicated. And this is what Dan was getting at. All the different products, all the different cannabinoids, I mean all the different bioactive terpenes and everything else in the material, all different forms of administration. That is where it gets super complicated to really define what that is. And then of course, there's so little research we don't really know what all those constituents do. ASHLEY GLODE: Now that we kind of have a little bit of familiarity with medical cannabis, can you comment on adult use cannabis and what that might mean for a patient? ILANA BRAUN: Ashley, I think it's a really good question. And in some of the early research I did to try to understand where medicinal ended and adult use began, or adult use ended and medicinal began, I began to discover a theme that emerged, which is they sort of blend into each other often. In other words, some of the oncologists that I spoke to believed that it was not such a bad thing for a patient with serious illness, and pain, and many other symptoms to have a sense of high or well-being. And conversely, when I spoke to patients using cannabis, sometimes a cancer patient used medicinal cannabis for enjoyment, and sometimes they used it for symptom management, and sometimes they used it for both. And so I think it is somewhat of a slippery slope between the two. Would you agree? DANIEL BOWLES: I think there are definitely blurred lines between the two. I think that the advantages of what most states would recognize as medicinal cannabis is usually they're less expensive, patients can use them in larger quantities. There are certain advantages. But there's also paperwork that goes along with medicinal cannabis that some patients don't feel comfortable with. Or particularly I think when you have a patient who's interested in trying cannabis or a cannabinoid for the first time, they might not want to go through all the extra steps required getting that medical marijuana card, whereas adult use, I think people feel more comfortable, at least in my state, sometimes walking into a dispensary to discuss the options with people who work at the dispensary and then get it from more of an adult use or recreational cannabis initially. And then if that's something that they find helpful for their symptom management, to then take those extra steps and try to get a medicinal card. ILANA BRAUN: I agree with Dr. Bowles that the target symptoms or the target effect is often similar and access can differ. KENT HUTCHISON: Yeah. Just to chime in, I agree. I agree also. It's definitely-- the lines get blurred. The recreational user might also appreciate-- for example, college students, I hear them say a lot of times that they appreciate some of the anxiety-reducing aspects-- right-- even though they're not necessarily a person who has an anxiety disorder. And then of course, patients appreciate a slight increase in euphoria or positive affect, and what does that mean? Is I mean they're also using for recreational reasons? Or is that completely, I guess, legitimate? On the other hand, there are sometimes I feel like when-- especially on the recreational side-- when people are using for the more psychological effects, the sort of psychotropic effects, I know sometimes the medical patients refer to that as being a little bit loopy as a side effect. So I feel like there's definitely some blurred lines. And maybe there are some places where we can think about in perhaps in a less blurred kind of way. ASHLEY GLODE: How often do you guys have a patient ask you about medical cannabis? And what are the most common questions they might have for you? ILANA BRAUN: In my psycho-oncology practice, patients frequently tell me they're using cannabis, often with good effect and minimal side effects for polysymptom management-- for instance to address nausea, or pain, or poor appetite, or sleep, or mood, or quality of life. But they don't ask me a lot of questions. For instance, one of my longest-standing patients. A man with metastatic cancer and gastroparesis. Vaporizes cannabis before meals to keep his weight up. And many of my patients also use cannabis as cancer-directed therapy. And for these patients, side effects can sometimes be more pronounced. For instance, I have a lovely patient with metastatic cancer who follows a Rick Simpson protocol. So what is that? That's an online recipe marketed with an antineoplastic claim. And so this patient targets hundreds milligrams of cannabinoids daily. And with such high cannabinoid doses, she sometimes feels spicy, or out of it, as she describes it. And then I had another patient who targeted high daily doses and developed a debilitating nausea and vomiting that was initially diagnosed as chemotherapy-induced nausea vomiting because it was so hard to tease out in the setting of so many medicinal agents, what was what. But the symptoms resolved completely within weeks of the cannabinoids being halted. And so as I mentioned, what's notable about all three of these patients, and many of the others I see, is that they are quite open with their oncology teams and me about their medicinal cannabis use. But they don't seem to rely me or other members of their oncology team for their therapeutic advice . We insert ourselves when we see potential harm, but much of the decision-making seems to be made-- I don't know in the naturopath's office, at the dispensary counter, or by trial and error. And this anecdotal experience in my practice is borne out in my research findings as well. Patients are just not getting the bulk of their cannabis therapeutics information from their medical teams. DANIEL BOWLES: In my clinical practice, I am asked about cannabis or cannabinoids a fair, amount often in the context that Dr. Braun is describing, where a patient is coming in and they're already using a cannabinoid or they are planning on doing it and they just want my opinion. And I think unlike talking about more conventional cancer-directed therapies where they really rely, I think, on their medical team for information and guidance, we are often more a supplement I think in terms of information. In terms of the patients who come to ask me about cannabis or let me know that they're using cannabis, it's a very wide selection of people. I see young people, old people talking about it, men, women, a variety of different malignancies. So there really is a lot of usage or are thought about usage of cannabis or cannabinoids amongst our cancer patients. I think if you look at the studies, they'll tell us that depending on where we're working, anywhere between 20% to 60% of patients have used cannabis in the last year to help manage some sort of cancer-related symptoms. And I think the other thing that is notable is you'll find people asking about cannabis or cannabinoids who I think we might not have otherwise expected. So for instance, Just this past week, I had a patient with anaplastic thyroid cancer in his 70s, and his daughter was wondering whether he could try CBD to help with his sleep and anxiety. She wanted to make sure that it wasn't going to interact with this cancer therapies. And I appreciated her bringing it up, and we could have a frank discussion about the pluses and minuses of it, just like we might any other therapeutic intervention. So I think that particularly as the laws have changed across the country, more and more people are willing to tell us that they're trying cannabinoids and cannabis than maybe would have even 10 or 15 years ago. KENT HUTCHISON: I think in an ideal world, patients would be talking a lot more with their physicians about this topic. And I think unfortunately that a lot of people do get their information from dispensaries. From the media, from social media, from their kids, and from whoever. And I think that's something that I hope will change in the future. DANIEL BOWLES: In terms of questions that I'm often asked, I'll be asked if it's going to interact with their cancer treatments, in terms of making their medications more or less effective. I do get questions about how I think their cannabis use might affect some of their symptoms. I get questions about other drug-drug interactions-- let's say, interactions with opiates, or benzodiazepines, or some of these other medications that a lot of our patients are on. ASHLEY GLODE: In a recent survey 80% of medical oncologists who discussed medical cannabis with their patients, 50% recommended it in the past year, but only 30% felt knowledgeable enough to make recommendations. What do you guys think needs to be done to address this knowledge gap? And what resources do clinicians have to get and stay informed? DANIEL BOWLES: So I'm a big fan of the NCI's PDQ as a great resource. It has a fairly objective information about cannabis and cancer specifically. So I think that's a nice reference for people who are interested in getting an initial overview on the topic. I think there are also a number of different educational programs. I know the University of Colorado, for instance, has a Cannabis Science Master's and also a certificate program. So there are courses available for people who want to educate themselves more on this topic. ILANA BRAUN: Yeah. I guess when I think about what needs to be done, I think that cannabis needs to become a routine part of medical training curricula and CME programs. I think that a federal funding for high-quality clinical trials and a loosening of federal restrictions on accessing study drug were to occur, that would be really a big boon for the medical community. And my colleagues on this podcast I know are doing some very creative pragmatic clinical trials naturalistic studying what is happening in the field. And I am doing clinical trials using an FDA-approved version of cannabinoids. But it's still very hard to study whole-plant cannabis in a form that is sort of a standardized trial drug in a cancer patient. And then when I think about where I would begin to read, I don't think there is a single source, unfortunately. But a great place to start reading is actually a project that Dr. Hutchinson was a part of, which was an expert panel that was assembled by the National Institute of Science Engineering and Medicine in 2017. And they produced a monograph on the health effects of cannabis and cannabinoids. And it's several hundred pages long, including sections devoted just to oncology. So in other words, there is scientific evidence to evaluate, and it's sizable. DANIEL BOWLES: The Austrian Center for Cannabinoid Clinical and Research Excellence also is a helpful resource. One of the nice things about that is they actually give some dosing suggestions or ideas for people who really don't quite know where to start. Right now, there aren't a lot of people in that position to say, here's how it should be done. Here's how it gets dosed. Here are the data to support those decisions. And so the folks in the next level of training don't learn it in the same way that we have learned how to prescribe other medications. And they can't then lay it down. So because the data are scant, in some respects, and particularly for herbal products that So. Many of our patients are using, I think it falls outside the medical model that we've all become so used to using to learn how to take care of patients. And I think that's one reason that so many oncology providers feel interested in learning more about this topic, but don't feel comfortable giving patients guidance on how to use them. KENT HUTCHISON: So both Dr. Braun and Dr. Bowles identified some of the key resources out there. And certainly the training issues that Dr. Bowles just talked about are important. And I do want to emphasize the one thing that Dr. Braun mentioned, which is basically that we do-- we lack research and we lack data on some key important issues, like dosing, for example. What dose is effective? So cannabidiol has been out there for a long time, but what dose is effective for what? We don't know, right? So we definitely lack research. And there are definitely obstacles to doing that research. ASHLEY GLODE: So you guys brought up some good points about there being a lack of data, but also there is some evidence. So what is the current research and evidence on the efficacy of medical cannabis for management of cancer symptoms and cancer pain, specifically? DANIEL BOWLES: So there was a really nice review article that just came out in the BMJ looking at cannabis and cannabinoids, not specific to cancer pain, but including cancer pain. And what they found-- they looked at different preparations from herbal products-- smoked herbal products, oral agents-- cannabinoids, more specifically. They found there is a modest, but a real improvement in pain in patients or research subjects treated with cannabinoids versus those usually typically treated with placebo. In particular, the data are supported in neuropathic pain, I'd say more so than the other pains. I think the data are less compelling with regards to many of the other symptoms that people often use cannabinoids for, such as sleep, anxiety, appetite, things along those lines. ILANA BRAUN: So I'll tell you a little bit about how I think about the evidence base in oncology for cannabis use. So I'll preface this with two points. The first is that, as I mentioned, cannabis products tend not to be one active ingredient, but hundreds of active ingredients-- cannabinoids, phenols, terpenes, they all have bioactivity. And they don't work individually, they work through complicated synergistic and inhibitory interactions that have been termed entourage effects. So I don't think one can easily extrapolate from clinical trials of, say, purified THC, to understand whole-plant cannabis' activity in the body and how it might perform in humans. And then the other point I'll make is that when I think about the types of clinical evidence that we as clinicians hold dearest, it's clinical trials of our agent of interest in our population of interest. So cancer patients using whole-plant full-spectrum cannabis that they would access at a dispensary or grow in their own home. With this in mind, I believe the strongest evidence, randomized double-blind placebo controlled trials of whole-plant cannabis and oncology populations begins to support its utility for chemotherapy-induced nausea and vomiting. So there have been a few studies that have looked at this. But just in 2020, the most recent is a study by Grimison, et al. It was a multicenter randomized double-blind placebo controlled crossover trial comparing cannabis extract. And I think the extract they use was a 1 to 1 THC to CBD ratio versus a placebo in patients with refractory chemotherapy-induced nausea and vomiting. And what they found was that with active drug, there was a complete response in 25% of participants versus only 14% with the placebo. And although a third of participants experienced additional side effects with the active drug-- so remember, this was a crossover trial, so they saw both arms-- 80% preferred cannabis to the placebo medication. So that's clinical trials of cannabis and cancer. But if we expand the base of the pyramid of acceptable evidence to include high-quality clinical trials for health conditions other than cancer and extrapolate back, then I agree fully with Dr. Bowles that there's a growing body of evidence that cannabis may be beneficial in pain management. And there have been many clinical trials done in this arena, and they span myriad pain syndromes, including diabetic neuropathy, post-surgical pain, MS pain, sickle cell pain. And so it does seem like cannabis works for pain management in several other illness models, so we could extrapolate back and hope that it works in cancer pain. And then there is a small body of evidence with nabiximols, which is a pharmaceutical that has a 1 to 1 THC to CBD ratio. And it's a sublingual metered dose spray. And it has been trialed for opioid-resistant cancer pain. And this is not as a single agent, but as an adjuvant to opioids. In early trials, two times as many participants in the active arm as compared to the placebo arm demonstrated a 30% pain reduction. And for the pain specialists who are listening, they will know that is a substantial pain reduction. But then, additional studies fail to meet primary endpoints. I think there were three clinical trials that followed. Nabiximols was found to be safe and effective by some secondary measures, but the FDA opted not to approve nabiximols for cancer pain. So I think there's some suggestion of effect, but there's some smoke, but no fire-- no pun intended. DANIEL BOWLES: I think many of the studies that have been done looking at cannabis-- or cannabinoids-- have been compared to placebo or they've been crossover. And I would say fairly consistently, there is some improvement in pain scores with the cannabis products versus placebo kind of across a wide variety of disease spectrums with regards to pain. I think one of the other questions that a lot of people have asked is, can you decrease people's opiate usage using cannabis? As we know, there's a huge epidemic of opiate misuse in the United States of America right now. And I think many people are looking for ways to decrease opiate usage. There was a nice study done from Minnesota in conjunction with the Minnesota dispensaries-- or state marijuana program-- where some researchers randomized people to starting kind of herbal cannabis products early in their study or three months into their study. So it was kind of a built-in control. And they looked at opiate usage rates, pain scores, quality of life scores, et cetera. What they found is there, again, was some improvement in pain control overall in the cannabis users. However, it did not equate to a decrease in opiate usage. So I think that it's an open question that I think a lot of people want to know the answers to before they start recommending or incorporating cannabis or cannabinoids more widely into their practice. KENT HUTCHISON: It's certainly a complicated issue, in some ways, right? Because the research which is summarized very nicely by both Dr. Braun and Dr. Bowles, it is suggested, but not overwhelming, by any stretch, right? It's not clear-cut. And I think that one of the big issues here we talked about the very beginning is how complicated this cannabis thing is. and Dr. Braun alluded to this also, that there are obviously many different formulations, many potentially active constituents in cannabis. And so what has mostly been studied so far is either synthetic versions of THC or nabiximols, which is probably the closest thing to what some people are using. So I think the jury's still out, for sure. And I think hopefully at some point, what will happen is that some of the products that are actually being used by people-- because most people aren't using nabiximols, most people are not using THC only, hopefully there'll be some trials of the things that people are actually using out there in the real world that will tell us something more about whether it's effective or not. And maybe even more specifically, which constituents-- which parts, together are most effective with respect to pain. DANIEL BOWLES: I think one of the other topics that some of my colleagues have alluded to already is not just cannabis' role in symptom management. I think pain is often what people think of, and people are using it for chemo-induced nausea and vomiting, anxiety, sleep, appetite, but a fair number of patients are also using cannabis or cannabinoids with the hopes that it is going to treat their cancer like a chemotherapy or an immunotherapy may. And oftentimes, patients will point to preclinical studies looking at oftentimes very high doses of THC or CBD that might show tumor cell death or tumor reduction in test tubes. And I spent a fair amount of time-- and I know some of my colleagues spent a fair amount of time-- talking with patients about how it's a big step between cannabis or cannabinoids working to slow cancer growth in a test tube, to working in an animal system, to working in people. ASHLEY GLODE: So what are the most important considerations clinicians should keep in mind before recommending medical cannabis to patients with cancer? DANIEL BOWLES: We should be asking why they want to use cannabinoids. I think just like we might any other medication that people are thinking about trying-- or herbal product that people are thinking about trying-- I think we need to ask why they're interested in using these products. So is it for symptom management? Is it for some of the ancillary side effects of cannabinoids or cannabis? Why are they wanting to use it? And I think trying to incorporate that more than into the medical model, I ask my patients, hey, if you're using this particular product, do you feel like it's doing what you intended it for it to do? If it is and it's legal in your state, great. Do it as you feel fit. If it's not meeting your goals, if it's not helping with the pain, or if it's not helping with the anxiety, or it's not helping with the nausea and vomiting, maybe we should rethink whether we would use it. Just as if I was prescribing more conventional anti-nausea medication and you didn't think it was working, we wouldn't keep using it. So I think that's a really important thing to keep in mind. I think the other thing to know from a safety standpoint is, who else is in the household? We have a psychiatrist on the call with us today. I think there is an ample amount of data that cannabis is not safe for young people. It's not safe for growing brains. And I think we need to make sure, just as we would want people's opiates to be secured, that their cannabinoids and cannabis products are secured as well, from those who do not want to use them. ILANA BRAUN: And the thing I would keep in mind is that in most states, giving patients a medicinal cannabis card is allowing them to access any number of products with different ratios of active ingredients, delivery mechanisms, onset of action, potencies. And if you don't discuss all of these issues with your patients, these are things that they will decide at the dispensary counter, or by discussing with friends and family, or by trial and error. And I think it's really important that we clinicians guide this narrative. ASHLEY GLODE: So what kinds of patients are not good candidates for medical cannabis? DANIEL BOWLES: I would not recommend medical cannabis for people who can't meet some of the criteria we already discussed. So people who can't keep it safe in their households or have concerns about diversion in their own households. Those are people who I think would not be great candidates for medicinal cannabis or cannabinoids. ILANA BRAUN: As the psychiatrist on the call, I would add that I worry for people with a strong history of psychosis, or currently psychotic, or with a strong family history of psychosis. And perhaps those severely immunocompromised, since there is evidence of fungal and mold contamination in some cannabis products. DANIEL BOWLES: The other group of people I discussed this with are patients on immunotherapies. One of the ways that cannabis may be effective in some of the symptoms we discussed is it's an anti-inflammatory agent. One of the ways it could be detrimental for patients on immunotherapies is that it's an anti-inflammatory agent. There is one small study that suggested that patients might have worse responses to immunotherapy who are cannabis users versus those who are not. So that is a conversation I like to have, just so patients feel like they can be informed. I think lastly, cannabis even for people with medical cards, is not free. So there can be a financial burden for people who are using it. So that's something that I'll often bring up with people as well. KENT HUTCHISON: One thing I would add to this would be history of a substance use disorder might also be a consideration here as well. Mainly because you don't know what the person is going to get, and it could be something that lends itself to relapse or encourages a problem. So I would add that to list. ILANA BRAUN: And I would second what Dr. Bowles said about the financial challenges of using cannabis regularly medicinally. It's not something that's covered by insurance, either. So these are out-of-pocket expenses, and they can add up fast, particularly for patients in the oncology space using it for antineoplastic therapy. ASHLEY GLODE: So is there a concern about drug-drug interactions for patients currently undergoing active cancer treatment? DANIEL BOWLES: There are some data that there can be drug-drug interactions with cannabis and certain agents. In particular, cannabidiol, or CBD, is a CYP3A4 inhibitor. And there are a lot of drugs that are metabolized through that particular system. So I think that that's the clinical relevance of those interactions, I think, is sometimes unknown. But that is another topic that I do think we need to make sure we bring up with our patients. ASHLEY GLODE: Thank you. Yeah. So a lot of what we'll do is from a drug interaction perspective, use the FDA-approved products that we have available to run through a drug interaction checker, like Dr. Bowles mentioned. So we'll use dronabinol as the THC-based product and epidiolex as the CBD-based product. There's also some resources, such as natural Medicines Database. And some of the pharmacy programs that we use, you can actually put in marijuana or cannabis as a drug and run drug interaction checks. So there's multiple potential interactions, like he mentioned, through the immune system. But through the cytochrome P450 pathway, cannabis has been shown in some instances to be an inhibitor, sometimes an inducer of certain enzymes, as well as a substrate. So it's really important to work with your pharmacy colleagues to run through different potential interactions that may be present. ILANA BRAUN: I'll just add one thing, just in case that's helpful. I mentioned earlier in the episode that I had a patient who used cannabis as an antineoplastic drug, and targeted very high doses and developed a terrible nausea and vomiting. And when she stopped, so did the nausea and vomiting, even though her chemotherapeutic continued. And I, to this day, don't know if that was a cyclic nausea and vomiting syndrome, which has been known to plague some heavy cannabis users, or whether drug-drug interactions led to her high-dose cannabis triggering high blood concentrations of her cancer-directed therapy at the time. And so I think that drug-drug interactions do need to be carefully weighed. ASHLEY GLODE: So wrapping up, has the medical community stance on medical marijuana shifted in recent years with legalization in many states? ILANA BRAUN: I don't think we know the answer to this, about how sentiment has shifted because there aren't longitudinal studies that I know of examining this question. But we need some. And one could imagine that as medicinal cannabis becomes are commonplace, providers are increasingly confronted with questions about how to guide care and the desire for high-quality clinical trials and in-depth cannabis therapeutics trainings increases-- and as one piece of evidence for this, at the end of 2020 the National Cancer Institute held a first-in-kind four-day conference at the intersection of cannabis and cancer. And so I'm hopeful that grant opportunities will follow from that. DANIEL BOWLES: I think overall there has been more willingness to discuss cannabis in the context of patient care in the last decade. A couple of ways that I see this is I much more frequently see cannabis use described not necessarily in the drug history, or in the social history, but in the medical history, or in their medications, if they're using it for medical or therapeutic purposes. I think the other place that I've noticed cannabis usage become a bit more mainstream is in the clinical trial setting-- not in clinical trials of cannabis, but one of the things that many of us do is clinical trials of new drugs. And very frequently, 10 years ago we ran into trouble trying to get our patients who were using cannabis products for cancer symptom control onto these clinical trials because of potential drug-drug interactions, or just the fear of the unknown. And I feel like we run into that less commonly now. KENT HUTCHISON: I think it's also worth pointing out that there have been more and more podcasts like this one, right? So to the credit of this organization, I think we are seeing some change. I just wanted to highlight that. And I compliment everyone here for putting us together and putting it out there. ASHLEY GLODE: All right. Well, thank you. That is all we have for today. And thank you very much Drs. Braun, Bowles, and Hutchison for a delightful conversation. Thank you so much to all the listeners tuning into this episode of the ASCO Education Podcast. [MUSIC PLAYING]   SPEAKER: Thank you for listening to this week's episode to make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit elearning.asco.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Vikash Kumar Singh, an alumnus of the batch of 2009 from the Department of Computer Science Engineering, is a fashion and portrait photographer based in London. His works have been published in internationally acclaimed magazines, exhibited in several spots, and have won him several honorable awards. Link to the full article: https://mondaymorning.nitrkl.ac.in/article/2021/11/22/3169-glitter-on-the-lens-vikash-kumar-singh/

Our guest this week is Miles Munroe, Lead Distiller for Westward Whiskey. Westward is reimagining Single Malt and adding an American Whiskey spin to elevate the category. American Single Malt Whiskey is a growing category and Westward is one to lead the charge as the United States moves towards well-defined standards of identity for the category. Miles brings a brewer's mentality to whiskey-making and goes above and beyond to craft high quality whiskies in Portland Oregon. Download this episode on your favorite podcast player by clicking here.  We are thankful for everyone who has supported us in 2021. A huge shoutout to our growing Patreon Community as well! We'd appreciate it if you can take the time to give us feedback on our podcast. If you enjoy our content, consider giving us a 5 star rating on your favorite podcast app, leave us a review, and tell a fellow bourbon lover about our show. Follow  us @BourbonLens on Instagram, Facebook, & Twitter.  And please check out our Patreon to learn how you can support our endeavors, earn Bourbon Lens swag, be part of future barrel picks, and more. If you have any comments, questions, or suggestions, please email us at TheBourbonLens@Gmail.com. Visit our website BourbonLens.com to check out our blog posts, or even purchase your own Bourbon Lens tasting glass or t-shirt. Cheers,Scott, Jake, & MichaelBourbon Lens ABOUT WESTWARD AMERICAN SINGLE MALT WHISKEY: Single Malt, reimagined. American whiskey, elevated.  As the highest rated American Single Malt, Westward Whiskey began in 2004 with a vision: to make a distinctive American Single Malt inspired by the American Northwest and the culture, climate, and abundant natural resources that have earned the region such reverence and renown. From humble beginnings to its impressive footprint today, creating a bold, robust, and delicious American Single Malt has remained the team's true passion. Helmed by founders Thomas Mooney and Christian Krogstad, Westward is a trailblazer in the American craft spirits community, a leading voice for American Single Malt, and a co-founder of the American Single Malt Whiskey Commission. Westward's flagship family of whiskeys, which have earned high praise around the world (two Double Gold medals, San Francisco World Spirits Competition), are available nationwide and in select international markets, include the original Westward American Single Malt, Westward American Single Malt Stout Cask, and Westward American Single Malt Pinot Noir Cask. For more information go to www.WestwardWhiskey.com and follow @westwardwhiskey on Facebook or Instagram. ABOUT MILES MUNROE: Miles Munroe serves as the lead distiller of Westward Whiskey. Miles manages the distilling production team and ensures that every bottle of Westward is made to perfection. His day-to-day responsibilities include spearheading all blending sessions and supervising Westward's rigorous quality controls by signing off on all whiskies before both barreling and  bottling. He also oversees all operations within the Westward warehouse in Clackamas, the company's 28,000 square foot facility that maintains an inventory of more than 3,000 barrels of aging whiskey at any given time. Miles joined Westward Whiskey in 2013 to increase production of the company's American Single Malt. He began as the company's only production distiller, making up to two barrels per week. Today, Miles manages a team of six distillers who collectively produce 25 barrels per week. Miles played an integral role in optimizing spirits manufacturing at Westward's new distillery, a 13,000 square facility in Southeast Portland which opened in 2015 and expanded whiskey capacity six-fold. During the planning and build- out process, Miles served as a critical distilling consultant, determining equipment needs, designing the work flow, and calculating capacity for product. Miles' aptitude for taste plays a key role in ensuring quality while also sparking his creativity. After developing a custom flavor wheel for Westward to properly define its profile, he was inspired by his brewing experience to incorporate stout beer into a cask finish, which naturally paired well with Westward's signature characteristics. This resulted in the brand's first-ever stout cask finish, a four-year aged Westward resting for eight months in an Imperial Stout barrel that will launch later this year. As all of the company's distillers do, Miles came to Westward with a background in brewing. He attended the American Brewers Guild and graduated from the institute's Science & Engineering of Brewing program before spending several years as a brewer in Portland, OR. It was during his time studying sensory analysis that he realized his talent for taste and flavor identification, a skill that has brought him to achieve great success as brewer and later a whiskey blender. Over the course of his career, he worked for Bridgeport Brewing, Lompoc Brewing, and Migration Brewing, all while focusing on his end goal of becoming a whiskey distiller. Show Links: Westward Whiskey  The Club – Westward Whiskey Westward Whiskey (@westwardwhiskey) • Instagram photos and videos Maxim - Best New American Single Malt Whiskies of 2021 Westward Whiskey Club Sends Exclusive Bottles Straight to Your Home | Get Access to Whiskeys You Can't Find Anywhere Else Tasting: 3 American Single Malts From Westward Whiskey - Paste A drink with... Thomas Mooney, Westward Whiskey - The Spirits Business Interview: Christian Krogstad / Founder and Master Distiller of Westward Whiskey – The Right Spirit Is This America's Best Single Malt Whiskey? | Man of Many Westward Single Malt Whiskey – Tempranillo Cask Finish – The Right Spirit Miles Munroe from Westward Whiskey - Cocktails Distilled At Westward, Making Great Whiskey Starts With Making Great Beer

What's a trumpet have to do with data management?  Meet co-hosts Joe Hellerstein and Jeff Heer in this first episode of The Data Wranglers, where they discuss and riff on data engineering, analytics, data science and all things modern data management.

Today, we're bringing you a conversation with Dr. Ian Hutchinson, professor of nuclear science and engineering at MIT's plasma science and fusion center. In addition to him answering our questions about the very nature of that mysterious fourth state of matter, we also explored hurdles in fusion technology, pernicious problems of ideological anchoring in academic science, and the looming crisis of scientism. Our discussion was so wide-ranging that we absolutely must have Dr. Hutchinson back again! We're particularly curious about his latest research on space weather and its impact on everyday life. Stay tuned for that one! Support the podcast by becoming a Patron @DemystifySci ª º¬˚∆≤≥≤≥ https://www.patreon.com/demystifysci ≤≥≤≥∆˚¬ºª ªº¬˚∆≤≥≤≥ Join the mailing list https://bit.ly/3v3kz2S​ ≤≥≤≥∆˚¬ºª Check our main channel, @DemystifyingScience for in depth-investigations: https://youtu.be/1OCL5Lq8m6s Dr. Ian Hutchinson: https://www-internal.psfc.mit.edu/~hutch/ PODCAST INFO: Blog: http://demystifyingscience.com/blog Apple Podcasts: https://apple.co/3uhn7J1 Spotify: https://spoti.fi/39IDJBD RSS: https://anchor.fm/s/2be66934/podcast/rss Donate: https://bit.ly/3wkPqaD Swag: https://bit.ly/2PXdC2y SOCIAL: - Twitter: https://twitter.com/demystifysci - Facebook: https://www.facebook.com/groups/demystifyingscience - Instagram: https://www.instagram.com/demystifysci/ MUSIC: Shilo Delay: worldwide and @ https://soundcloud.com/laterisgone --- Support this podcast: https://anchor.fm/demystifying-science/support

Waleed Nasir is a Board Member and District Vice President at Yale Science and Engineering Association, and Head of Sales at Virtual Force Inc where he manages a global team of 100+ designers, engineers, growth hackers and social media marketers. LinkedIn: https://www.linkedin.com/in/waleednasir

Welcome back to another episode of Minds behind Maps!In this episode I sit down with Bruno Sánchez-Andrade Nuño, the Program Director of the Planetary Computer at Microsoft as well as the author of "Impact Science: The science of getting to radical social and environmental breakthroughs". About Bruno:Twitter: https://twitter.com/brunosanLinkedIn: https://www.linkedin.com/in/nasonurb/Website: https://brunosan.eu/Bruno's book "Impact Science, The science of getting to radical social and environmental breakthroughs": https://www.goodreads.com/book/show/46137268-impact-science?ac=1&from_search=true&qid=jvKJBnRM5k&rank=1"Impact Science" on Amazon: https://www.amazon.com/gp/product/B07SN1L4L2/ref=dbs_a_def_rwt_bibl_vppi_i1 Timestamps:4:20 : Conversation starts, Bruno presents himself10:30 : How Bruno entered Academia14:20 : Science / Engineering duality18:05 : Skills over Knowledge21:15 : How education could be more skill centered29:05 : How Bruno entered geospatial31:51 : At the edge of human knowledge of the Sun36:07 : Leaving NASA to focus on more applied projects40:04 : Trying to work for an NGO: “Bruno we don't need a rocket scientist”47:53 : Cheap Data Science51:20 : Limitations & Playfulness for clever ideas55:18 : Writing “Impact Science”1:05:01 : From outputs to outcomes: a missing layer in Data Science1:11:08 : Data Informed instead of Data Driven1:17:44: Bruno's work at Microsoft as Program Director of the Planetary Computer1:33:18: Partnerships within the Planetary Computer project1:38:25 : Books & media recommendations Show notes:OpenStreetMap: https://www.openstreetmap.orgFast.ai : Applicable Machine Learning framework & lessonsKaggle.com: Data Science competition platformOrigin of the term data science (under 'Etymology'): https://en.m.wikipedia.org/wiki/Data_scienceBruno's Medium blog post “In Defense of Cheap Data Science”: https://towardsdatascience.com/in-defense-of-cheap-data-science-f630f248d400Chai time data science interview of Jeremy Howard: https://www.youtube.com/watch?v=205j37G1cxwIndia's night light mapping project: http://india.nightlights.io/Microsoft's Planetary Computer: https://planetarycomputer.microsoft.com/Book recommendations:A Short History of Nearly Everything by Bill BrysonThe Martian by Andy WeirHumankind by Rutger BregmanFactfulness by Hans RoslingBruno's Goodread: https://www.goodreads.com/author/show/19228134.Bruno_S_nchez_Andrade_Nu_oI'm sorry I couldn't find the story related to Youtube's video loading times! Please feel free to reach out!My Twitter: https://twitter.com/MaxLenormandReach out by email: minds.behind.maps@gmail.comFor news about the podcast: https://twitter.com/MindsBehindMaps

How has the quantum revolution allowed researchers a new understanding of light? By examining the properties and behavior of light, discoveries like gravity waves can be found. Press play to learn: How quantum optics function Why pairs of photons are quantum correlated What the signal to noise ratio signifies Ryan T. Glasser, Ph.D., an Associate Professor at Tulane EDU, School of Science & Engineering, stops by to share his work with quantum optics and discusses what this work may hold for the future. A higher-quality image can be gained by quantizing light in a specific way, allowing a more extended range for optics to be used effectively. By quantum correlating the pairs of photons, accurate measurements, even beyond lasers, can be created. By eliminating "noise" in calculations using quantum optics, the data collected from the experiment can be much more dependable. This is in part the quality of quantum optics that allowed a team of researchers to earn a Nobel prize for discovering gravity waves. To learn more, visit https://glasser.tulane.edu.

OTG goes on a brief tour of the new facility which opens in September.

Sergey Karelov is a Founder and Chief Technology Officer, Witology, Chairman of the Board of the League of Independent Experts, RIAC Expert, technology evangelist. In the 1980s, he was the sales director of one of the first Russian computer companies, Interkvadro, and then the founder and owner of Systems and Projects Ltd, which became the first IBM business partner in the USSR. In the 1990s, he was a top manager of the Russian IBM and the head of regional departments of SGI and Cray Research. Since 2001 he has been an independent consultant in the field of advanced technologies. Since 2004 - Chairman of the Board of the League of Independent Experts LINEX. In 2009, he became a co-founder and ideologist of Witology, a startup in the field of collective intelligence. Candidate of Science (Engineering). He runs a popular telegram channel about the "little-known interesting" at the intersection of science, technology, business and society - and its mirrors on Facebook, Medium and Yandex.Zen. FIND SERGEY ON SOCIAL MEDIA LinkedIn | Facebook | Telegram | Medium ================================ SUPPORT & CONNECT: Support on Patreon: https://www.patreon.com/denofrich Twitter: https://twitter.com/denofrich Facebook: https://www.facebook.com/denofrich YouTube: https://www.youtube.com/denofrich Instagram: https://www.instagram.com/den_of_rich/ Hashtag: #denofrich © Copyright 2022 Den of Rich. All rights reserved.

This week we're interviewing Sivan Aldor-Noiman. A powerhouse leader, mom of two boys, and VP of Data Science and Data Engineering at a food-technology company. We're going to talk with Sivan about her background and career, her own support system, the day-to-day or her role, and how she got there. We think you'll love her advice and outlook on life and hope you feel bolder, braver and ready to take on the world after listening. Here's what our co-host, Polina, has to say about this week's interview: "I especially love this episode because I was lucky to have worked with Sivan for over two years and she is definitely among the most interesting and empathetic people I have ever worked with. I have learnt so much from her and I am sure you will too!" Let's jump in and meet Sivan!

Today's guest is Deepna Devkar, Vice President of Data Science & Engineering at CNN Digital where she heads up the Data Intelligence team in New York. She works to understand the CNN audience across devices and build recommendation systems that increase user engagement across all CNN brands. Deepna has worked primarily in the media industry with strong experience building and leading cross-functional teams. She enjoys working on projects ranging across audience segmentation, content recommendation and personalization. In 2018, she was recognized for her contribution as Folio's Top Women in Media, Corporate Champion. In the episode, Deepna will discuss: Her interesting Data Science journey to joining CNN, How they are applying Data Science to transform CNN Digital, Transitioning from academia into industry, Challenges to be aware of moving into Leadership roles, How to build a successful Data Science team, Advice on how to kick start your Data Science career, And What she loves about her role at CNN.

THIS IS NOT A PODCAST BY ME. THIS IS AN OPPORTUNITY FOR ME TO SHARE AN EXAMPLE OF THE GREAT LECTURES THAT ARE AVAILABLE, DURING THIS GREAT DARWIN FESTIVAL. PROFESSOR GEOFF LEVERMORE GAVE ME PERMISSION TO SHARE HIS LECTURE, CLIMATE CHANGE, SCIENCE, ENGINEERING AND THE DENIERS. THIS WAS A GREAT TALK ABOUT CLIMATE CHANGE, GREENHOUSE GASSES AND THE PROBLEMS THAT THEY ARE CAUSING TO THE PLANET. I DID NOT CREATE THIS, THIS IS THE WORK OF PROFESSOR LEVERMORE AND I THANK HIM GREATLY FOR LETTING ME SHARE THIS. I ALSO THANK THE ORGANISERS AT THE UNITARIAN CHURCH IN SHREWSBURY FOR BRINGING THIS EVENT TO THE TOWN. I HOPE YOU ENJOY THIS. MORE GREAT SHOWS TO COME TO YOU TOMORROW AND THROUGHOUT THE DARWIN FESTIVAL.

Social visibility doesn't influence culture. Only service does. Assigned Reading: – Idols for Destruction: The Conflict of Christian Faith and American Culture, Herbert Schlossberg